Area of research
Epidemiology · Infectious Diseases
Research interest
Research interests include Antifungal resistance and susceptibility, Fungal Infections and Studies, Nail Diseases and Treatments, and Gut microbiota and health.
Treatment of onychomycosis in an era of antifungal resistance: Role for antifungal stewardship and topical antifungal agents
Dermatophytomas in Onychomycosis: A Scoping Review of Prevalence, Diagnosis, and Treatment
Antifungal Activity of Efinaconazole Compared with Fluconazole, Itraconazole, and Terbinafine Against Terbinafine- and Itraconazole-Resistant/Susceptible Clinical Isolates of Dermatophytes, Candida, and Molds
Ibrexafungerp, a Novel Triterpenoid Antifungal in Development for the Treatment of Mold Infections
Cutaneous dysbiosis may amplify barrier dysfunction in patients with atopic dermatitis
Therapeutic Recommendations for the Treatment of Toenail Onychomycosis in the US
Ibrexafungerp Versus Placebo for Vulvovaginal Candidiasis Treatment: A Phase 3, Randomized, Controlled Superiority Trial (VANISH 303)
Ibrexafungerp: A Novel Oral Triterpenoid Antifungal in Development for the Treatment of Candida auris Infections
Treatment-resistant dermatophytosis: A representative case highlighting an emerging public health threat
Treatment‐resistant tinea corporis, a potential public health issue
Alterations in the oral microbiome in HIV-infected participants after antiretroviral therapy administration are influenced by immune status
Cetylpyridinium Chloride (CPC) Exhibits Potent, Rapid Activity Against Influenza Viruses in vitro and in vivo
Bacteriome and Mycobiome Interactions Underscore Microbial Dysbiosis in Familial Crohn’s Disease
High Accuracy of Common HIV-Related Oral Disease Diagnoses by Non-Oral Health Specialists in the AIDS Clinical Trial Group
Wild-Type MIC Distributions and Epidemiological Cutoff Values for Amphotericin B, Flucytosine, and Itraconazole and Candida spp. as Determined by CLSI Broth Microdilution